BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16304050)

  • 1. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma.
    Ushmorov A; Leithäuser F; Sakk O; Weinhaüsel A; Popov SW; Möller P; Wirth T
    Blood; 2006 Mar; 107(6):2493-500. PubMed ID: 16304050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.
    Ushmorov A; Ritz O; Hummel M; Leithäuser F; Möller P; Stein H; Wirth T
    Blood; 2004 Nov; 104(10):3326-34. PubMed ID: 15284123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
    Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
    J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.
    Hertel CB; Zhou XG; Hamilton-Dutoit SJ; Junker S
    Oncogene; 2002 Jul; 21(32):4908-20. PubMed ID: 12118370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
    Bohle V; Döring C; Hansmann ML; Küppers R
    Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription.
    Stein H; Marafioti T; Foss HD; Laumen H; Hummel M; Anagnostopoulos I; Wirth T; Demel G; Falini B
    Blood; 2001 Jan; 97(2):496-501. PubMed ID: 11154228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
    Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of microRNA expression in Hodgkin lymphoma.
    Navarro A; Díaz T; Cordeiro A; Beyá MD; Ferrer G; Fuster D; Martinez A; Monzó M
    Leuk Lymphoma; 2015; 56(9):2683-9. PubMed ID: 25586608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells.
    Yuki H; Ueno S; Tatetsu H; Niiro H; Iino T; Endo S; Kawano Y; Komohara Y; Takeya M; Hata H; Okada S; Watanabe T; Akashi K; Mitsuya H; Okuno Y
    Blood; 2013 Feb; 121(6):962-70. PubMed ID: 23212521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
    Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
    Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype.
    Ehlers A; Oker E; Bentink S; Lenze D; Stein H; Hummel M
    Leukemia; 2008 Apr; 22(4):835-41. PubMed ID: 18256685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation.
    Bose S; Starczynski J; Chukwuma M; Baumforth K; Wei W; Morgan S; Byrd P; Ying J; Grundy R; Mann JR; Tao Q; Taylor AM; Murray PG; Stankovic T
    J Pathol; 2007 Nov; 213(3):329-36. PubMed ID: 17876757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease.
    Jundt F; Kley K; Anagnostopoulos I; Schulze Pröbsting K; Greiner A; Mathas S; Scheidereit C; Wirth T; Stein H; Dörken B
    Blood; 2002 Apr; 99(8):3060-2. PubMed ID: 11929801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
    Schwering I; Bräuninger A; Distler V; Jesdinsky J; Diehl V; Hansmann ML; Rajewsky K; Küppers R
    Mol Med; 2003; 9(3-4):85-95. PubMed ID: 12865944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
    Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
    BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Schwering I; Bräuninger A; Klein U; Jungnickel B; Tinguely M; Diehl V; Hansmann ML; Dalla-Favera R; Rajewsky K; Küppers R
    Blood; 2003 Feb; 101(4):1505-12. PubMed ID: 12393731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
    Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
    Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
    Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
    Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
    Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
    Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.